[Stimulation of bone formation by statins].
Komatsu
Yasato
Y
Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine.
Nakao
Kazuwa
K
D000818:Animals; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000235:genetics / Q000378:metabolism; D001862:Bone Resorption / Q000517:prevention & control; D002455:Cell Division / Q000187:drug effects; D002986:Clinical Trials as Topic; D050723:Fractures, Bone / Q000209:etiology / Q000517:prevention & control; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D000960:Hypolipidemic Agents; D010006:Osteoblasts / Q000166:cytology; D010012:Osteogenesis / Q000187:drug effects*; D010024:Osteoporosis / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D013268:Stimulation, Chemical; D016212:Transforming Growth Factor beta
C525718:BMP2 protein, human; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D016212:Transforming Growth Factor beta